|
|
 |
|
Viewing report
|
|
|
|
Valuing and Structuring Pharmaceutical Licensing Agreements
PharmaVentures, Oct 2003, Pages: 101
This publication provides an essential grounding in how to use accepted and reliable methods for valuing pharmaceutical and biotech projects. Whether you are about to negotiate a licensing deal or need to perform a rigorous portfolio review, it is vital that you understand both the value of a project today and how that value can be built over time.
The methods presented here provide answers to both questions through the combination of historical analysis of what the market has been willing to pay for similar products and technologies, and forward-looking projections that explicitly handle the issues of risk, time, cost and reward. Potential elements of deals are also discussed, as are the appropriate levels of risk and reward sharing, and the significance of individual company needs and preferences. When incorporated into the valuation models that have been built, these elements will permit the development of deal structures that are attractive to both sides.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Guide to Valuation of Pharmaceutical Licensing Deals
Effective Deal Making in Drug Delivery
The Royalty Rate Report 2010: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
Vitacon Drug Valuation Model™
The Royalty Rate Report 2009 - A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
Trends in Pharmaceutical Deal Making: An Analysis of Valuations, Deal Structures and Deal Types
Effective Licensing & Commercialisation of Drug Delivery Systems 2006
Biotechnology Valuation: An Introductory Guide
Transdermal Drug Delivery - Technologies, Markets, and Companies
Pricing and Reimbursement Risk and Opportunities in Pharmaceutical Deal Making
Cell-Based Assays for Drug Discovery
Drug Delivery Technology - Revolutionizing CNS Therapies
|
|
|
|
